[Results of the clinical experimentation with CB 4261 (Tetrazepam) affecting spasticity in neurologic diseases. Use of secondary effects (56 cases)].
作者信息
Turon R, Lagrave F
出版信息
Bord Med. 1970 Sep;3(9):2193-204.
PMID:5481197
Abstract
摘要
相似文献
1
2
[Therapy of spastic syndromes].
Bibl Psychiatr Neurol. 1969;139:114-23.
3
[Neuroleptics, thymoleptics and tranquilizers in neurological therapy].[神经疗法中的抗精神病药、抗忧郁药和镇静剂]
Bibl Psychiatr Neurol. 1969;139:88-113.
4
[Trial of a new anxiolytic agent (RO-4556) in cardiologic practice].
Mars Med. 1970;107(9):683-7.
5
6
[Central acting muscle relaxants].
Tidsskr Nor Laegeforen. 1974 Sep 30;94(27):1660-4.
7
[Tacitin in psychoautonomic disorders].[他克莫司在精神自主神经功能紊乱中的应用]
Fortschr Med. 1973 Jan 18;91(2):77-81.
8
[Use of tetrazepam in the treatment of contractures during neurological diseases].
J Med Lyon. 1969 Oct 5;50(172):1337-42.
9
[Treatment of psychoneurosis by medazepam--with special reference to therapy of disorders of autonomic nervous system].美达西泮治疗神经症——特别提及自主神经系统紊乱的治疗
Saishin Igaku. 1971 Mar;26(3):553-62.
10
Clinical evaluation of a new muscle relaxant (chlormethazanone).一种新型肌肉松弛剂（氯美扎酮）的临床评估
J Indiana State Med Assoc. 1959 Jul;52(7):1134-6.
Zotero 插件